APA

Ivashchenko A. V., Iamanushkin P. M., Mit'kin O. D., Ezhova E. V., Korzinov O. M., Shevkun N. A., Karapetian R. N., Bychko V. V., Ivashchenko A. A., Agrba V. Z., Lapin B. A., Orlov S. V. & Kuznetsov I. É. (20150910). [Preclinical study of safety of the new pharmacological substance AV0012 to treat hepatitis C]. : Eksperimental'naia i klinicheskaia farmakologiia.

Chicago

Ivashchenko A V, Iamanushkin P M, Mit'kin O D, Ezhova E V, Korzinov O M, Shevkun N A, Karapetian R N, Bychko V V, Ivashchenko A A, Agrba V Z, Lapin B A, Orlov S V and Kuznetsov I É. 20150910. [Preclinical study of safety of the new pharmacological substance AV0012 to treat hepatitis C]. : Eksperimental'naia i klinicheskaia farmakologiia.

Harvard

Ivashchenko A. V., Iamanushkin P. M., Mit'kin O. D., Ezhova E. V., Korzinov O. M., Shevkun N. A., Karapetian R. N., Bychko V. V., Ivashchenko A. A., Agrba V. Z., Lapin B. A., Orlov S. V. and Kuznetsov I. É. (20150910). [Preclinical study of safety of the new pharmacological substance AV0012 to treat hepatitis C]. : Eksperimental'naia i klinicheskaia farmakologiia.

MLA

Ivashchenko A V, Iamanushkin P M, Mit'kin O D, Ezhova E V, Korzinov O M, Shevkun N A, Karapetian R N, Bychko V V, Ivashchenko A A, Agrba V Z, Lapin B A, Orlov S V and Kuznetsov I É. [Preclinical study of safety of the new pharmacological substance AV0012 to treat hepatitis C]. : Eksperimental'naia i klinicheskaia farmakologiia. 20150910.